Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $13.1 million.

  • Perspective Therapeutics' Accounts Payables fell 3972.4% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 3972.4%. This contributed to the annual value of $10.3 million for FY2024, which is 4970.33% up from last year.
  • Per Perspective Therapeutics' latest filing, its Accounts Payables stood at $13.1 million for Q3 2025, which was down 3972.4% from $7.0 million recorded in Q2 2025.
  • Over the past 5 years, Perspective Therapeutics' Accounts Payables peaked at $21.8 million during Q3 2024, and registered a low of $730000.0 during Q2 2021.
  • For the 5-year period, Perspective Therapeutics' Accounts Payables averaged around $5.4 million, with its median value being $3.9 million (2023).
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 46408.07% in 2024, then plummeted by 3972.4% in 2025.
  • Perspective Therapeutics' Accounts Payables (Quarter) stood at $847000.0 in 2021, then skyrocketed by 81.94% to $1.5 million in 2022, then skyrocketed by 348.35% to $6.9 million in 2023, then soared by 49.7% to $10.3 million in 2024, then rose by 27.12% to $13.1 million in 2025.
  • Its Accounts Payables was $13.1 million in Q3 2025, compared to $7.0 million in Q2 2025 and $8.7 million in Q1 2025.